{"database": "openregs", "table": "federal_register", "rows": [["2012-27004", "Draft Guidance for Industry on Bioequivalence Recommendation for Lenalidomide Capsules; Availability", "Notice", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Draft Guidance on Lenalidomide.\" The guidance provides specific recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for lenalidomide capsules. The draft guidance is a revised version of a previously published draft guidance on the subject.", "2012-11-06", 2012, 11, "https://www.federalregister.gov/documents/2012/11/06/2012-27004/draft-guidance-for-industry-on-bioequivalence-recommendation-for-lenalidomide-capsules-availability", "https://www.govinfo.gov/content/pkg/FR-2012-11-06/pdf/2012-27004.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Draft Guidance on Lenalidomide.\" The guidance provides specific recommendations on the design of bioequivalence (BE) studies to support...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2012-27004"], "units": {}, "query_ms": 1.3596349745057523, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}